FFO
GBIO

Fortitude Family Office’s Generation Bio GBIO Stock Holding History

Fortitude Family Office’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-335
Closed -$8.28K – 1325
2024
Q3 		$8.28K Buy
+335
New +$8.86K ﹤0.01% 622

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fortitude Family Office's GBIO Position: Q4 2024 in Review

Fortitude Family Office sold out of Generation Bio (GBIO) in Q4 2024, closing a stake of 335 shares — an estimated $8.28K sold.

Fortitude Family Office first reported a position in GBIO in Q3 2024 and held it in 1 quarter. The position peaked at $8.28K in Q3 2024. 78 funds tracked by Wall St. Rank hold GBIO as of Q4 2024.

  • Fortitude Family Office reported no remaining Generation Bio position as of Q4 2024 after selling out during the quarter.
  • Fortitude Family Office sold 335 Generation Bio shares in Q4 2024, an estimated $8.28K.
  • Fortitude Family Office first reported a position in Generation Bio in Q3 2024 and held it in 1 quarter.
  • Fortitude Family Office's Generation Bio position peaked at $8.28K in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Generation Bio as of Q4 2024.

Based on Fortitude Family Office's 13F filing for Q4 2024, filed 10 Jan 2025.